These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alkylating agents as leukemogens in multiple myeloma. Karchmer RK; Amare M; Larsen WE; Mallouk AG; Caldwell GG Cancer; 1974 Apr; 33(4):1103-7. PubMed ID: 4522494 [No Abstract] [Full Text] [Related]
3. Acute leukaemia after alkylating-agent therapy of ovarian cancer. Bell DR; Woods RL; Levi JA Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879 [No Abstract] [Full Text] [Related]
4. [Leukemia in tumor patients receiving chemotherapy]. Fopp M; Senn HJ Dtsch Med Wochenschr; 1985 Sep; 110(38):1439-41. PubMed ID: 3861311 [No Abstract] [Full Text] [Related]
5. [Acute myeloproliferative syndrome after alkylating agent treatment in a case of multiple myeloma]. Gardella S; Cervantes F; Bladé J; Brugués R; Rozman C Med Clin (Barc); 1982 Sep 1-15; 79(4):185-8. PubMed ID: 7144293 [No Abstract] [Full Text] [Related]
6. Acute leukemia after alkylating-agent therapy of ovarian cancer. Reimer RR; Hoover R; Fraumeni JF; Young RC N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560 [TBL] [Abstract][Full Text] [Related]
7. Leukemia after treatment of ovarian cancer with alkylating agents. Parker LM N Engl J Med; 1983 Jun; 308(23):1422. PubMed ID: 6843637 [No Abstract] [Full Text] [Related]
8. [The effect of antineoplastic alkylating agents on the serum protein fraction of rats with sarcoma 45]. Kulik GI; Pel'kis FP Vopr Onkol; 1969; 15(7):68-71. PubMed ID: 4980425 [No Abstract] [Full Text] [Related]
10. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs. Cardamone JM; Kimmerle RI; Marshall EY Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270 [No Abstract] [Full Text] [Related]
11. [Plasmocytoma, alkylating agents, and acute myeloid leukemia (author's transl)]. Schmalzl F; Keiser G; Kresbach E; Fritz H; Asamer H; Braunsteiner H Dtsch Med Wochenschr; 1975 Sep; 100(39):1961-7. PubMed ID: 1057506 [TBL] [Abstract][Full Text] [Related]
13. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer and acute leukemia in a patient with multiple myeloma treated with melphalan. Meytes D; Katz DR Isr J Med Sci; 1973 Aug; 9(8):1044-7. PubMed ID: 4753846 [No Abstract] [Full Text] [Related]
15. Acute myeloid leukaemia after treatment with cytostatic agents. Smit CG; Meyler L Lancet; 1970 Sep; 2(7674):671-2. PubMed ID: 4195813 [No Abstract] [Full Text] [Related]
18. [Secondary leukemia following chemotherapy of various malignancies]. Abe T; Tsuda S; Takino T Gan No Rinsho; 1984 Sep; 30(12 Suppl):1543-52. PubMed ID: 6513006 [TBL] [Abstract][Full Text] [Related]
19. [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases]. Krulik M; Grolleau JY; Audebert AA; Mougeot-Martin M; Harousseau JL; Hervouet D; Debray J Sem Hop; 1977 Dec; 53(42):2425-35. PubMed ID: 203043 [TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma and acute leukemia associated with alkylating agents. Kyle RA; Pierre RV; Bayrd ED Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]